Jubilant DraxImage Revenue and Competitors

Kirkland, QC CAN

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Jubilant DraxImage's estimated annual revenue is currently $40.4M per year.(i)
  • Jubilant DraxImage's estimated revenue per employee is $201,000

Employee Data

  • Jubilant DraxImage has 201 Employees.(i)
  • Jubilant DraxImage grew their employee count by -10% last year.

Jubilant DraxImage's People

NameTitleEmail/Phone
1
technical laboratoryReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.2M167%N/AN/A
#2
$30.2M1501%N/AN/A
#3
$10.7M1005%$39.7MN/A
#4
$104.3M51922%N/AN/A
#5
$47.8M238N/AN/AN/A
#6
$15.5M775%N/AN/A
#7
$395.8M19697%N/AN/A
#8
$187.3M9326%N/AN/A
#9
$361.6M17996%N/AN/A
#10
$27.5M1370%N/AN/A
Add Company

What Is Jubilant DraxImage?

Jubilant DraxImage Inc. is a world-class nuclear medicine company, headquartered in Montreal, Canada, with a solid foundation in specialty pharma. They develop, manufacture and commercialize radiopharmaceuticals worldwide used for the diagnosis and treatment of various diseases. The company has over 170 highly skilled employees dedicated to providing high quality and reliable products to health care providers for more than 60 years. JDI's broad portfolio of products includes diagnostic and therapeutic agents, as well as state-of-the-art devices, for cardiology, oncology, pulmonology, and endocrinology. Their corporate values focus on cultivating world-class talent committed to quality and innovation, with a promise of providing the highest quality radiopharmaceuticals and advanced technologies to healthcare professionals, so they can provide the highest quality care to their patients.

keywords:N/A

N/A

Total Funding

201

Number of Employees

$40.4M

Revenue (est)

-10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Jubilant DraxImage News

2022-04-17 - Global Therapeutic Nuclear Medicines Market 2022 Trending ...

Novartis AG, Bayer, China Isotope & Radiation, Q BioMed, Curium Pharmaceuticals, Jubilant DraxImage, Dongcheng, Lantheus,...

2022-04-17 - Iodine-131 Market Size, Share, Growth 2022-2030| Key ...

Jubilant DraxImage; NTP; IRE – IRE ELiT. Iodine-131 Market Breakdown by Type: Solution; Capsule. Iodine-131...

2022-04-13 - Global Iodine-131 Market 2022 Industry Overview, COVID-19 ...

Jubilant DraxImage; NTP; IRE – IRE ELiT. Geographical regions included, such as. North America (United States, Canada and Mexico); Europe (...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$60.3M2039%N/A
#2
$64.4M21714%N/A
#3
$57.2M217-15%$155M
#4
$50.8M220-2%N/A
#5
$54.1M2349%N/A